Tech Company Financing Transactions
Aursos Funding Round
Private investors participated in a $450 thousand funding round for Aursos. The round closed on 9/30/2008.
Transaction Overview
Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$450,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
350 E. Michigan Ave. 500
Kalamazoo, MI 49007
USA
Kalamazoo, MI 49007
USA
Phone
Website
Email Address
Overview
Aursos (pronounced R-sos) was founded in March of 2007. The Company has licensed technology developed at Michigan Technological University in the laboratory of Dr. Seth Donahue on the family of naturally-occurring parathyroid Hormone (PTH) proteins found in the black bear (Ursus americanus).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Zinn
Chief Financial Officer
Terry Lewis
Chief Scientific Officer
Ronald Shebuski
Browse more venture capital transactions:
Prev: 9/30/2008: Treemo venture capital transaction
Next: 9/30/2008: YottaMark venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs